Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Radhashree Maitra

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Frontiers in Oncology|November 17, 2022
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancerTitto Augustine, Peter John, Tyler Friedman, et al.
BMC Cancer|June 5, 2026
The prognostic significance of B7-H3 expression in patients with advanced colorectal cancerYan Huang, Ana Acuna-Villaorduna, Radhika Gali, et al.
Clinical Colorectal Cancer|March 22, 2021
B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal CancerWei Zhang, Ana Acuna-Villaorduna, Kevin Kuan, et al.
Investigational New Drugs|August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumorsMohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Frontiers in Oncology|November 17, 2022
Potentiating effect of reovirus on immune checkpoint inhibition in microsatellite stable colorectal cancerTitto Augustine, Peter John, Tyler Friedman, et al.
BMC Cancer|June 5, 2026
The prognostic significance of B7-H3 expression in patients with advanced colorectal cancerYan Huang, Ana Acuna-Villaorduna, Radhika Gali, et al.
Clinical Colorectal Cancer|March 22, 2021
B7-H3 and PD-L1 Expression Are Prognostic Biomarkers in a Multi-racial Cohort of Patients with Colorectal CancerWei Zhang, Ana Acuna-Villaorduna, Kevin Kuan, et al.
Investigational New Drugs|August 3, 2024
A phase I safety and efficacy clinical trial of plocabulin and gemcitabine in patients with advanced solid tumorsMohammad H Ghalib, Mariano Provencio Pulla, Maria J De Miguel Luken, et al.
Oncotarget|October 1, 2019
Excision repair cross-complementing group-1 (ERCC1) induction kinetics and polymorphism are markers of inferior outcome in patients with colorectal cancer treated with oxaliplatinDevika Rao, Atrayee Basu Mallick, Titto Augustine, et al.
Pageof 5